148 related articles for article (PubMed ID: 33685623)
1. Retraction notice to "Efficacy of Bisphosphonates against Hip Fracture in Elderly Patients with Stroke and Parkinson Diseases: Meta-analysis of Randomized Controlled Trials" [Journal of Stroke and Cerebrovascular Diseases, Vol. 23, No. 10 (November-December), 2014: pp 2714-2724].
Zhang W; Zhu C; Sun M; Ge Y; Yan G
J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105682. PubMed ID: 33685623
[No Abstract] [Full Text] [Related]
2. RETRACTED: Efficacy of bisphosphonates against hip fracture in elderly patients with stroke and Parkinson diseases: meta-analysis of randomized controlled trials.
Zhang W; Zhu C; Sun M; Ge Y; Yan G
J Stroke Cerebrovasc Dis; 2014; 23(10):2714-2724. PubMed ID: 25314942
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oral bisphosphonates for preventing hip fracture in disabled patients with neurological diseases: a meta-analysis of randomized controlled trials among the Japanese population.
Iwamoto J; Takeda T; Matsumoto H
Curr Med Res Opin; 2011 Jun; 27(6):1141-8. PubMed ID: 21456887
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.
Iwamoto J; Matsumoto H; Takeda T
Curr Med Res Opin; 2008 May; 24(5):1379-84. PubMed ID: 18384711
[TBL] [Abstract][Full Text] [Related]
5. Retraction notice to "Impact of the COVID-19 Pandemic on Stroke Epidemiology and Clinical Stroke Practice in the US" [Journal of Stroke and Cerebrovascular Diseases, Vol. 30, No. 4 (April), 2021: 105639].
Friedlich D; Newman T; Bricker S
J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105982. PubMed ID: 34256928
[No Abstract] [Full Text] [Related]
6. Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: A meta-analysis.
Peng J; Liu Y; Chen L; Peng K; Xu Z; Zhang D; Xiang Z
Pak J Med Sci; 2016; 32(2):499-504. PubMed ID: 27182270
[TBL] [Abstract][Full Text] [Related]
7. Retraction notice to "An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients" [Journal of Stroke and Cerebrovascular Diseases, Volume 20, Issue 1, January-February 2011, Pages 41-46].
Sato Y; Iwamoto J; Honda Y
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104426. PubMed ID: 31668218
[No Abstract] [Full Text] [Related]
8. Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.
Pratt N; Roughead EE; Salter A; Ryan P
BMC Med Res Methodol; 2012 Jun; 12():72. PubMed ID: 22682666
[TBL] [Abstract][Full Text] [Related]
9. Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials.
Nguyen ND; Eisman JA; Nguyen TV
J Bone Miner Res; 2006 Feb; 21(2):340-9. PubMed ID: 16526127
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis for the efficacy of bisphosphonates on hip fracture prevention.
Tsuda T; Hashimoto Y; Okamoto Y; Ando W; Ebina K
J Bone Miner Metab; 2020 Sep; 38(5):678-686. PubMed ID: 32236684
[TBL] [Abstract][Full Text] [Related]
11. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
Chen L; Wang G; Zheng F; Zhao H; Li H
Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
Zhou J; Ma X; Wang T; Zhai S
Osteoporos Int; 2016 Nov; 27(11):3289-3300. PubMed ID: 27273112
[TBL] [Abstract][Full Text] [Related]
14. Retraction notice to "Beneficial Effect of Etidronate Therapy in Chronically Hospitalized, Disabled Patients with Stroke" [Journal of Stroke and Cerebrovascular Diseases, Volume 19, Issue 3, May 2010, Pages 198-203].
Sato Y; Iwamoto J; Honda Y
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2362. PubMed ID: 31375260
[No Abstract] [Full Text] [Related]
15. Retraction notice to "Risk factors for hip fracture among elderly patients with Parkinson's disease" [Journal of the Neurological Sciences 182 (2001), 89-93].
Sato Y; Kaji M; Tsuru T; Oizumi K
J Neurol Sci; 2024 Jan; 456():122821. PubMed ID: 38087765
[No Abstract] [Full Text] [Related]
16. Retraction notice to "Risk factors for hip fracture among elderly patients with Alzheimer's disease" [Journal of the Neurological Sciences 223 (2004), 107-112].
Sato Y; Kanoko T; Satoh K; Iwamoto J
J Neurol Sci; 2024 Jan; 456():122823. PubMed ID: 38044180
[No Abstract] [Full Text] [Related]
17. The effect of regional nerve block on perioperative delirium in hip fracture surgery for the elderly: A systematic review and meta-analysis of randomized controlled trials.
Kim CH; Yang JY; Min CH; Shon HC; Kim JW; Lim EJ
Orthop Traumatol Surg Res; 2022 Feb; 108(1):103151. PubMed ID: 34826609
[TBL] [Abstract][Full Text] [Related]
18. Hydroids (Cnidaria, Hydrozoa) from Mauritanian Coral Mounds.
Gil M; Ramil F; AgÍs JA
Zootaxa; 2020 Nov; 4878(3):zootaxa.4878.3.2. PubMed ID: 33311142
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates in multiple myeloma: a network meta-analysis.
Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
[TBL] [Abstract][Full Text] [Related]
20. Retraction Notice to "Accelerated Bone Remodeling in Patients with Poststroke Hemiplegia" [Journal of Stroke and Cerebrovascular Diseases, Volume 7, Issue 1, January-February 1998, Pages 58 - 62].
Sato Y; Fujimatsu Y; Honda Y; Kunoh H; Kikuyama M; Oizumi K
J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104425. PubMed ID: 31784024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
